Showing results (51-60 of 94) with videos related to
Sort By:
Pageof 10
Human Genome Variation|December 10, 2020
Novel COL4A1 mutations identified in infants with congenital hemolytic anemia in association with brain malformationsHiromi Ogura, Shouichi Ohga, Takako Aoki, et al.Pediatric Radiology|October 18, 2022
Usefulness of central radiologic review in clinical trials of children with hepatoblastomaOsamu Miyazaki, Eiji Oguma, Masanori Nishikawa, et al.International Journal of Hematology|December 28, 2024
Adjunctive effects of eltrombopag on immunosuppressive therapy for childhood aplastic anemiaKatsuhide Eguchi, Masataka Ishimura, Shouichi Ohga, et al.Pediatric Blood & Cancer|October 4, 2021
Feasibility of dose-dense cisplatin-based chemotherapy in Japanese children with high-risk hepatoblastoma: Analysis of the JPLT3-H pilot studyKenichiro Watanabe, Makiko Mori, Tomoro Hishiki, et al.The Journal of Clinical Endocrinology and Metabolism|June 22, 2022
Genetic Analysis of Pheochromocytoma and Paraganglioma Complicating Cyanotic Congenital Heart DiseaseTatsuki Ogasawara, Yoichi Fujii, Nobuyuki Kakiuchi, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 15, 2014
Bloodstream infection after stem cell transplantation in children with idiopathic aplastic anemiaRyoji Kobayashi, Hiromasa Yabe, Akira Kikuchi, et al.Transplantation and Cellular Therapy|October 8, 2023
Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia with a Busulfan, Fludarabine, and Melphalan Regimen: JPLSG JMML-11Kazuo Sakashita, Nao Yoshida, Hideki Muramatsu, et al.Eclinicalmedicine|February 22, 2024
The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solutionAllison F O'Neill, Angela Trobaugh-Lotrario, James I Geller, et al.Bone Marrow Transplantation|April 29, 2021
Effect of high-dose chemotherapy plus stem cell rescue on the survival of patients with neuroblastoma modified by MYCN gene gain/amplification and remission status: a nationwide registration study in JapanYuya Saito, Mitsuyoshi Urashima, Yoshiyuki Takahashi, et al.Bone Marrow Transplantation|September 11, 2021
Prognostic value of the revised International Prognostic Scoring System five-group cytogenetic abnormality classification for the outcome prediction of hematopoietic stem cell transplantation in pediatric myelodysplastic syndromeShohei Yamamoto, Motohiro Kato, Kenichiro Watanabe, et al.Pageof 10